Pluripotent stem cells and gene therapy

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Informatics. Official publication website can be found on muni.cz.
Authors

ŠIMARA Pavel MOTL Jason KAUFMAN Dan

Year of publication 2013
Type Article in Periodical
Magazine / Source Translational Research
MU Faculty or unit

Faculty of Informatics

Citation
Web PubMed
Doi http://dx.doi.org/10.1016/j.trsl.2013.01.001
Field Genetics and molecular biology
Keywords pluripotent stem cells; gene therapy
Description Human pluripotent stem cells represent an accessible cell source for novel cell-based clinical research and therapies. With the realization of induced pluripotent stem cells (iPSCs), it is possible to produce almost any desired cell type from any patient's cells. Current developments in gene modification methods have opened the possibility for creating genetically corrected human iPSCs for certain genetic diseases that could be used later in autologous transplantation. Promising preclinical studies have demonstrated correction of disease-causing mutations in a number of hematological, neuronal, and muscular disorders. This review aims to summarize these recent advances with a focus on iPSC generation techniques, as well as gene modification methods. We will then further discuss some of the main obstacles remaining to be overcome before successful application of human pluripotent stem cell-based therapy arrives in the clinic and what the future of stem cell research may look like.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.